BELLA

Diagnostic kits comprised of medical diagnostic assays for use in disease detection, screening, treating and monitoring, namely, monitoring COVID-19 and other infectious diseases; Respiratory rapid tests, namely, medical diagnostic assays for use in performing respiratory rapid tests related to COVID-19 and other infectious diseases; Medical diagnostic kits comprised of reagents and assays for use in disease detection, screening, treating and monitoring, including, monitoring COVID-19 and other infectious diseases and also including swabs, including nasal and throat swabs, and medical sample tubes; COVID-19 rapid tests comprising medical diagnostic reagents and assays for withdrawing and testing respiratory droplets and also including parts and fittings thereof

Downloadable computer application software for mobile phones, namely, software for covid-19 and other infectious disease identification; Downloadable computer application software for computers, namely, software for covid-19 and other infectious disease identification; Downloadable mobile applications for health screenings relating to COVID-19 and other infectious disease; Downloadable mobile applications for tracking and reporting health conditions and symptoms; Scientific apparatus and instruments, namely, COVID-19 rapid tests for withdrawing and testing respiratory droplets for clinical, medical, research, and scientific purposes and parts and fittings thereof; Material testing apparatus and instruments, for identifying and testing pathogens and biomarkers in respiratory droplets for clinical, medical, research, and scientific purposes related to COVID-19 and other infectious diseases; Apparatus for transmission of communication; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for clinical, medical, research, and scientific purposes, namely, for COVID-19 and other infectious diseases

Medical instruments, namely, biosensors for detecting Covid-19 and other infectious diseases in a patient; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for medical diagnostic purposes, namely, for COVID-19 and other infectious disease

Providing temporary use of online non-downloadable software for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases; Providing temporary use of online non-downloadable software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Providing temporary use of web-based software applications for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Software as a service (SAAS) services featuring software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Electronic storage of information concerning persons infected with contagious disease for the purpose slowing or stopping the spread of the disease under the guidance of state and local public health departments, and information concerning physical sites visited by persons infected with contagious disease for the purpose slowing or stopping the spread of the disease under the guidance of state and local public health departments

Healthcare services, namely, treatment of patients for infectious diseases or medical disorders; Medical and healthcare information, consultancy and advisory services relating to infections, viruses, SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Providing a web site featuring medical information; Health care services, namely, disease management programs; Telehealth services, namely, providing telemedicine and services in conjunction with providing medical and healthcare services; Mobile healthcare services in the field of Covid-19 and other infectious disease testing, health assessments, intravenous infusion therapy, facilitating appointments; Medical screening services in the field of Covid-19 and other infectious diseases in a patient; Polymerase chain reaction (PCR) testing, rapid body antigen testing, and nucleic acid amplification testing for identifying and testing pathogens and biomarkers in respiratory droplets for medical diagnostic purposes related to COVID-19 and other infectious diseases